Skip to main content
logo
Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
10.01
-0.08 (-0.79%)
At close: Jul 31, 2026, 4:00 PM EDT
10.10
+0.09 (0.90%)
After-hours: Jul 31, 2026, 4:29 PM EDT

TNXP Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
17.5613.1110.097.77--
Revenue Growth
74.84%29.85%29.94%---
Gross Profit
10.286.472.333.03--
Operating Income
-151.19-125.7-136.7-118.38-112.09-92.31
Net Income
-147.39-124.02-130.04-116.66-116.88-92.29
Earnings Per Share
-14.36-14.57-176.60---
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
185.47207.6498.7824.95120.23178.66
Total Debt
1.291.318.129.810.760.96
Net Cash (Debt)
184.18206.3390.6615.14119.47177.7
Net Cash Growth
40.43%127.59%498.99%-87.33%-32.77%134.57%
Net Cash Per Share
17.6424.24123.12---

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-125.58-99.84-60.93-102-98.05-75.56
Capital Expenditures
-5.06-3.37-0.12-7.9-48.15-35.31
Free Cash Flow
-130.64-103.21-61.05-109.9-146.2-110.86
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.56%49.34%23.07%38.97%--
Operating Margin
-861.16%-959.05%-1354.28%-1523.94%--
Pretax Margin
-861.61%-946.22%-1288.25%-1501.78%--
Profit Margin
-861.61%-946.22%-1288.25%-1501.78%--
FCF Margin
-744.12%-787.47%-604.76%-1414.75%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.8515.2414.333.04--